The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Traveling on a budget is possible with the right strategies. Learn effective ways to explore without breaking the bank.
10,571 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A new heavyweight in crypto treasuries is nearing a public listing. Evernorth, with a sizable XRP stash, aims to rede...
The UK gilt market is spiraling, with the 10-year yield climbing to a 17-year high, signaling renewed stress for pens...
Prentice Capital has exited its Compass position, reporting a zero stake after the latest quarter. This move highligh...
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Wall Street predicts these three AI stocks could double within four years as demand for AI infrastructure and memory ...
Global energy markets reel from an unprecedented disruption in energy supply. CEOs grappling with greatest energy sho...
Meta Platforms has shown strong top-line momentum, but rising AI-related costs and shifting margins could pressure ea...
After years of watching this stock trade at lofty valuations, a broad market sell-off finally creates an entry point....
As a CFP®, I see recurring investing mistakes that erode gains. This practical guide shows how to spot them and turn ...
In a historic U.S. mortgage milestone, Coinbase and Better Home & Finance launch the first conforming crypto-backed p...
Investors confront a triple threat as rating concerns, tariff fights, and Middle East risk collide, putting Indonesia...